A large increase in concentrations of cytosolic Ca2 ([Ca2+]c) generally causes release of prolactin, but there are two conditions in which TRH causes a marked rise in [Ca2+]c but prolactin release is inhibited: one is after pretreatment with dopamine and the other is after frequent pulses of TRH. Because TRH generates a large spike of [Ca2+]c in these two cases, the inhibition of prolactin release must occur at a step subsequent to the use in [Ca2+]c. The goal is to understand the mechanisms of inhibition by determining what processes in the cell are no longer able to respond to increases in [Ca2+]c.
The specific aims are: 1. To determine if the activation of the protein kinase C system by TRH still occurs when prolactin release is inhibited by dopamine pretreatment or by frequent TRH pulses. 1a) We will determine what isozymes of protein kinase C are present in normal lactotrophs and if they are still translocated by TRH when prolactin release is inhibited. 1b) We will determine if TRH is still capable of phosphorylating a well-characterized substrate of protein kinase C when prolactin release is inhibited. 2. To investigate whether calmodulin-dependent kinases can be activated by TRH when prolactin release is inhibited. 2a) We will determine whether elongation factor II, the substrate for Ca2+/calmodulin kinase III, can still by phosphorylated by TRH when prolactin release is inhibited. 2b) We will investigate whether TRH causes changes in the phosphorylation state of Ca2+/calmodulin kinase II and if the changes still occur when release is inhibited. In these first two aims, if we find effects, we will characterize them. 3. To isolate and characterize proteins whose phosphorylation is stimulated by TRH when prolactin release occurs but not when prolactin release is inhibited. We will determine what kinases can phosphorylate these proteins and why phosphorylation is inhibited when prolactin release is inhibited.
This aim will extend knowledge of mechanisms of inhibition beyond the characterized systems described in the first two aims. The information gained from these experiments will increase our understanding of desensitization that occurs beyond the level of second messengers.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD011487-16
Application #
3311576
Study Section
Endocrinology Study Section (END)
Project Start
1978-01-01
Project End
1996-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
16
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Cui, Z J; Hidaka, H; Dannies, P S (1996) KN-62, a calcium/calmodulin-dependent protein kinase II inhibitor, inhibits high potassium-stimulated prolactin secretion and intracellular calcium increases in anterior pituitary cells. Biochim Biophys Acta 1310:343-7
Sun, Z; Li, P S; Dannies, P S et al. (1996) Properties of human prolactin (PRL) and H27A-PRL, a mutant that does not bind Zn++. Mol Endocrinol 10:265-71
Rhee, H K; Sun, Z; Kim, S S et al. (1995) Biological activity and immunological reactivity of human prolactin mutants. Endocrinology 136:4990-5
Mastro, R M; Dannies, P S (1995) Lack of correlation of distribution of prolactin (PRL) charge isoforms with induction of PRL storage. Endocrinology 136:69-74
Cui, Z J; Gorelick, F S; Dannies, P S (1994) Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine. Endocrinology 134:2245-50
Arrandale, J M; Dannies, P S (1994) Inhibition of rat prolactin (PRL) storage by coexpression of human PRL. Mol Endocrinol 8:1083-90
Cui, Z J; Dannies, P S (1992) Thyrotropin-releasing hormone-mediated Mn2+ entry in perifused rat anterior pituitary cells. Biochem J 283 ( Pt 2):507-13
Pachter, J A; Law, G J; Dannies, P S (1991) Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion. Eur J Pharmacol 195:373-9
Law, G J; Pachter, J A; Thastrup, O et al. (1990) Thapsigargin, but not caffeine, blocks the ability of thyrotropin-releasing hormone to release Ca2+ from an intracellular store in GH4C1 pituitary cells. Biochem J 267:359-64
Reaves, B J; Van Itallie, C M; Moore, H H et al. (1990) Prolactin and insulin are targeted to the regulated pathway in GH4C1 cells, but their storage is differentially regulated. Mol Endocrinol 4:1017-26

Showing the most recent 10 out of 28 publications